Literature DB >> 16416065

[Atrial fibrillation: rate or rhythm control--individual patient management].

J O Schwab1, B Lüderitz.   

Abstract

The treatment of atrial fibrillation still remains challenging in everyday practice. Even after the introduction of catheter ablation, the decision-making process about the type of therapy became more complex. The recently published guidelines of the American Heart Association, the American College of Cardiology, and the European Society of Cardiology clearly show therapeutic approaches for different types of atrial fibrillation. The fear of thromboembolism still forces the physician to restore sinus rhythm and achieve optimized anticoagulation. Based on large studies, we are able to decide for each patient individually whether oral anticoagulation or ASA is required. Future studies in a large cohort of patients are still necessary to clarify the value of interventional therapy in conjunction with antiarrhythmic drug therapy. These will provide patients with safe therapy and high quality of life despite presenting paroxysmal or persistent atrial fibrillation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16416065     DOI: 10.1007/s00392-005-1412-x

Source DB:  PubMed          Journal:  Z Kardiol        ISSN: 0300-5860


  9 in total

1.  ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to develop guidelines for the management of patients with atrial fibrillation) developed in collaboration with the North American Society of Pacing and Electrophysiology.

Authors:  V Fuster; L E Rydén; R W Asinger; D S Cannom; H J Crijns; R L Frye; J L Halperin; G N Kay; W W Klein; S Lévy; R L McNamara; E N Prystowsky; L S Wann; D G Wyse
Journal:  Eur Heart J       Date:  2001-10       Impact factor: 29.983

2.  A comparison of rate control and rhythm control in patients with atrial fibrillation.

Authors:  D G Wyse; A L Waldo; J P DiMarco; M J Domanski; Y Rosenberg; E B Schron; J C Kellen; H L Greene; M C Mickel; J E Dalquist; S D Corley
Journal:  N Engl J Med       Date:  2002-12-05       Impact factor: 91.245

3.  A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation.

Authors:  Isabelle C Van Gelder; Vincent E Hagens; Hans A Bosker; J Herre Kingma; Otto Kamp; Tsjerk Kingma; Salah A Said; Julius I Darmanata; Alphons J M Timmermans; Jan G P Tijssen; Harry J G M Crijns
Journal:  N Engl J Med       Date:  2002-12-05       Impact factor: 91.245

Review 4.  International consensus on nomenclature and classification of atrial fibrillation; a collaborative project of the Working Group on Arrhythmias and the Working Group on Cardiac Pacing of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology.

Authors:  S Lévy; A J Camm; S Saksena; E Aliot; G Breithardt; H Crijns; W Davies; N Kay; E Prystowsky; R Sutton; A Waldo; D G Wyse
Journal:  Europace       Date:  2003-04       Impact factor: 5.214

5.  Is rate control or rhythm control preferable in patients with atrial fibrillation? Rate control is preferable to rhythm control in the majority of patients with atrial fibrillation.

Authors:  Rodney H Falk
Journal:  Circulation       Date:  2005-06-14       Impact factor: 29.690

6.  Pharmacological and ablative hybrid therapy of atrial fibrillation. Long-term effect on quality of life and arrhythmia-related symptoms.

Authors:  H Bielik; J Schrickel; N Shlevkov; A Yang; J O Schwab; A Bitzen; B Lüderitz; T Lewalter
Journal:  Z Kardiol       Date:  2005-09

Review 7.  [Atrial fibrillation -- interventional therapy with respect to age].

Authors:  Th Lewalter; B Lüderitz
Journal:  Dtsch Med Wochenschr       Date:  2005-03-24       Impact factor: 0.628

8.  Suppression of paroxysmal atrial tachyarrhythmias--results of the SOPAT trial.

Authors:  Monica Patten; Renke Maas; Peter Bauer; Berndt Lüderitz; Frank Sonntag; Miroslaw Dluzniewski; Robert Hatala; Grzegorz Opolski; Hans-Walter Müller; Thomas Meinertz
Journal:  Eur Heart J       Date:  2004-08       Impact factor: 29.983

9.  Prevention of atrial fibrillation after cardioversion: results of the PAFAC trial.

Authors:  Thomas Fetsch; Peter Bauer; Rolf Engberding; Hans P Koch; Jan Lukl; Thomas Meinertz; Michael Oeff; Ludger Seipel; Hans J Trappe; Norbert Treese; Günter Breithardt
Journal:  Eur Heart J       Date:  2004-08       Impact factor: 29.983

  9 in total
  2 in total

1.  Simultaneous angiographic imaging of ipsilateral pulmonary veins for catheter ablation of atrial fibrillation.

Authors:  B Strohmer; C Schernthaner; M Pichler
Journal:  Clin Res Cardiol       Date:  2006-09-08       Impact factor: 5.460

Review 2.  [Does every case of atrial fibrillation need to be treated?].

Authors:  B Lüderitz
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2009-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.